Lentiviral small hairpin RNA delivery reduces apical sodium channel activity in differentiated human airway epithelial cells

Journal of Gene Medicine

Volumn 14, Issue 12, 2012, Pages 733-745

  Aarbiou, Jamil ^a,h   Copreni, Elena ^b,i   Buijs Offerman, Ruvalic M ^a   van der Wegen, Pascal ^a   Castellani, Stefano ^b,c   Carbone, Annalucia ^c   Tilesi, Francesca ^d   Fradiani, Piera ^d   Hiemstra, Pieter S ^e   Yueksekdag, Guelnihal ^f   Diana, Anna ^g   Rosenecker, Joseph ^f   Ascenzioni, Fiorentina ^d   Conese, Massimo ^b,c   Scholte, Bob J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c UNIVERSITY OF FOGGIA   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^f UNIVERSITY OF MUNICH   (Germany)

^g UNIVERSITY OF BARI   (Italy)

^h Galapagos BV   (Netherlands)

ⁱ MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Cell biology; Cystic fibrosis; Lentiviruses; Respiratory medicine; RNA interference

Indexed keywords

ALPHA INTERFERON; CYCLIC AMP; EPITHELIAL SODIUM CHANNEL; GREEN FLUORESCENT PROTEIN; LENTIVIRUS VECTOR; MESSENGER RNA; SHORT HAIRPIN RNA; TOLL LIKE RECEPTOR 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; CYSTIC FIBROSIS; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; IN VIVO GENE TRANSFER; MEMBRANE POTENTIAL; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; VESICULAR STOMATITIS;

CELL LINE; EPITHELIAL CELLS; EPITHELIAL SODIUM CHANNELS; GENE EXPRESSION REGULATION; GENE ORDER; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; LENTIVIRUS; RESPIRATORY MUCOSA; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSDUCTION, GENETIC;

VESICULAR STOMATITIS VIRUS;

EID: 84871502719     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.2672     Document Type: Article

References (57)

1. Griesenbach U, Geddes DM, Alton EW. Gene therapy progress and prospects: cystic fibrosis. Gene Ther 2006; 13: 1061-1067.
2. Riordan JR. CFTR function and prospects for therapy. Annu Rev Biochem 2008; 77: 701-726.
3. Conese M, Ascenzioni F, Boyd AC, et al. Gene and cell therapy for cystic fibrosis: from bench to bedside. J Cyst Fibros 2011; 10(Suppl 2): S114-S128.
4. Grimm D. Small silencing RNAs: state-of-the-art. Adv Drug Del Rev 2009; 61: 672-703.
5. Sibley CR, Seow Y, Wood MJ. Novel RNA-based strategies for therapeutic gene silencing. Mol Ther 2010; 18: 466-476.
6. Tiemann K, Rossi JJ. RNAi-based therapeutics-current status, challenges and prospects. EMBO Mol Med 2009; 1: 142-151.
7. Durcan N, Murphy C, Cryan SA. Inhalable siRNA: potential as a therapeutic agent in the lungs. Mol Pharm 2008; 5: 559-566.
8. Griesenbach U, Kitson C, Escudero Garcia S, et al. Inefficient cationic lipid-mediated siRNA and antisense oligonucleotide transfer to airway epithelial cells in vivo. Resp Res 2006; 7: 26.
9. Robbins M, Judge A, Ambegia E, et al. Misinterpreting the therapeutic effects of siRNA caused by immune stimulation. Hum Gene Ther 2008; 19: 991-999.
10. Tiscornia G, Singer O, Verma IM. Design and cloning of lentiviral vectors expressing small interfering RNAs. Nat Protoc 2006; 1: 234-240.
11. Henry SD, van der Wegen P, Metselaar HJ, Tilanus HW, Scholte BJ, van der Laan LJ. Simultaneous targeting of HCV replication and viral binding with a single lentiviral vector containing multiple RNA interference expression cassettes. Mol Ther 2006; 14: 485-493.
12. ter Brake O. t Hooft K, Liu YP, Centlivre M, von Eije KJ, Berkhout B. Lentiviral vector design for multiple shRNA expression and durable HIV-1 inhibition. Mol Ther 2008; 16: 557-564.
13. Gu W, Putral L, McMillan N. siRNA and shRNA as anticancer agents in a cervical cancer model. Meth Mol Biol (Clifton, NJ) 2008; 442: 159-172.
14. Lee CC, Huang HY, Chiang BL. Lentiviral-mediated GATA-3 RNAi decreases allergic airway inflammation and hyperresponsiveness. Mol Ther 2008; 16: 60-65.
15. Boucher RC. Cystic fibrosis: a disease of vulnerability to airway surface dehydration. Trends Mol Med 2007; 13: 231-240.
16. + channel-overexpressing mice. Am J Resp Crit Care Med 2008; 177: 730-742.
17. Chen JH, Stoltz DA, Karp PH, et al. Loss of anion transport without increased sodium absorption characterizes newborn porcine cystic fibrosis airway epithelia. Cell 2010; 143: 911-923.
18. Collawn JF, Lazrak A, Bebok Z, Matalon S. The CFTR and ENaC debate - how important is ENaC in CF lung disease? Am J Physiol 2012; 302: L1141-L1146.
19. Canessa CM, Merillat AM, Rossier BC. Membrane topology of the epithelial sodium channel in intact cells. Am J Physiol 1994; 267: C1682-C1690.
20. Alvarez de la Rosa D, Canessa CM, Fyfe GK, Zhang P. Structure and regulation of amiloride-sensitive sodium channels. Annu Rev Physiol 2000; 62: 573-594.
21. Jain L, Chen XJ, Ramosevac S, Brown LA, Eaton DC. Expression of highly selective sodium channels in alveolar type II cells is determined by culture conditions. Am J Physiol 2001; 280: L646-L658.
22. Hummler E, Barker P, Gatzy J, et al. Early death due to defective neonatal lung liquid clearance in alpha-ENaC-deficient mice. Nat Genet 1996; 12: 325-328.
23. Helve O, Pitkanen OM, Andersson S, O'Brodovich H, Kirjavainen T, Otulakowski G. Low expression of human epithelial sodium channel in airway epithelium of preterm infants with respiratory distress. Pediatrics 2004; 113: 1267-1272.
24. Rauh R, Diakov A, Tzschoppe A, et al. A mutation of the epithelial sodium channel (ENaC) associated with atypical cystic fibrosis (CF) increases channel open probability and reduces Na+self inhibition. J Physiol 2010; 588: 1211-1225.
25. Azad AK, Rauh R, Vermeulen F, et al. Mutations in the amiloride-sensitive epithelial sodium channel in patients with cystic fibrosis-like disease. Hum Mutat 2009; 30: 1093-1103.
26. Yuan B, Latek R, Hossbach M, Tuschl T, Lewitter F. siRNA Selection Server: an automated siRNA oligonucleotide prediction server. Nucleic Acids Res 2004; 32: W130-W134.
27. Reynolds A, Leake D, Boese Q, Scaringe S, Marshall WS, Khvorova A. Rational siRNA design for RNA interference. Nat Biotechnol 2004; 22: 326-330.
28. Denti MA, Rosa A, Sthandier O, De Angelis FG, Bozzoni I. A new vector, based on the PolII promoter of the U1 snRNA gene, for the expression of siRNAs in mammalian cells. Mol Ther 2004; 10: 191-199.
29. Jenke AC, Eisenberger T, Baiker A, Stehle IM, Wirth S, Lipps HJ. The nonviral episomal replicating vector pEPI-1 allows long-term inhibition of bcr-abl expression by shRNA. Hum Gene Ther 2005; 16: 533-539.
30. Tiscornia G, Singer O, Verma IM. Production and purification of lentiviral vectors. Nat Protoc 2006; 1: 241-245.
31. Follenzi A, Ailles LE, Bakovic S, Geuna M, Naldini L. Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences. Nat Genet 2000; 25: 217-222.
32. van Wetering S, Zuyderduyn S, Ninaber DK, van Sterkenburg MA, Rabe KF, Hiemstra PS. Epithelial differentiation is a determinant in the production of eotaxin-2 and -3 by bronchial epithelial cells in response to IL-4 and IL-13. Mol Immunol 2007; 44: 803-811.
33. Spurgeon SL, Jones RC, Ramakrishnan R. High throughput gene expression measurement with real time PCR in a microfluidic dynamic array. PLoS One 2008; 3: E1662.
34. Caci E, Melani R, Pedemonte N, et al. Epithelial sodium channel inhibition in primary human bronchial epithelia by transfected siRNA. Am J Resp Cell Mol Biol 2009; 40: 211-216.
35. Galietta LJ, Folli C, Marchetti C, et al. Modification of transepithelial ion transport in human cultured bronchial epithelial cells by interferon-gamma. Am J Physiol 2000; 278: L1186-L1194.
36. + channel function. An in vitro model. J Biol Chem 2005; 280: 24181-24187.
37. Woollhead AM, Baines DL. Forskolin-induced cell shrinkage and apical translocation of functional enhanced green fluorescent protein-human alphaENaC in H441 lung epithelial cell monolayers. J Biol Chem 2006; 281: 5158-5168.
38. Kalali BN, Kollisch G, Mages J, et al. Double-stranded RNA induces an antiviral defense status in epidermal keratinocytes through TLR3-, PKR-, and MDA5/RIG-I-mediated differential signaling. J Immunol 2008; 181: 2694-2704.
39. Yount JS, Gitlin L, Moran TM, Lopez CB. MDA5 participates in the detection of paramyxovirus infection and is essential for the early activation of dendritic cells in response to Sendai virus defective interfering particles. J Immunol 2008; 180: 4910-4918.
40. Wang Q, Nagarkar DR, Bowman ER, et al. Role of double-stranded RNA pattern recognition receptors in rhinovirus-induced airway epithelial cell responses. J Immunol 2009; 183: 6989-6997.
41. Gitlin L, Barchet W, Gilfillan S, et al. Essential role of mda-5 in type I IFN responses to polyriboinosinic: polyribocytidylic acid and encephalomyocarditis picornavirus. Proc Natl Acad Sci USA 2006; 103: 8459-8464.
42. + channel in the pathogenesis and as a therapeutic target for cystic fibrosis lung disease. Exp Physiol 2009; 94: 171-174.
43. Itani OA, Auerbach SD, Husted RF, et al. Glucocorticoid-stimulated lung epithelial Na(+) transport is associated with regulated ENaC and sgk1 expression. Am J Physiol 2002; 282: L631-L641.
44. + transport in H441 distal lung epithelial cells: role of PKA, phosphatidylinositol 3-kinase, and sgk1. Am J Physiol 2004; 287: L843-L851.
45. Bals R, Beisswenger C, Blouquit S, Chinet T. Isolation and air-liquid interface culture of human large airway and bronchiolar epithelial cells. J Cyst Fibros 2004; 3(Suppl 2): 49-51.
46. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007; 9: 654-659.
47. Skog J, Wurdinger T, van Rijn S, et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 2008; 10: 1470-1476.
48. Pan Q, Ramakrishnaiah V, Henry S, et al. Hepatic cell-to-cell transmission of small silencing RNA can extend the therapeutic reach of RNA interference (RNAi). Gut 2011; 61: 1330-1339.
49. Buckley SM, Howe SJ, Sheard V, et al. Lentiviral transduction of the murine lung provides efficient pseudotype and developmental stage-dependent cell-specific transgene expression. Gene Ther 2008; 15: 1167-1175.
50. Kremer KL, Dunning KR, Parsons DW, Anson DS. Gene delivery to airway epithelial cells in vivo: a direct comparison of apical and basolateral transduction strategies using pseudotyped lentivirus vectors. J Gene Med 2007; 9: 362-368.
51. Liu C, Wong E, Miller D, Smith G, Anson D, Parsons D. Lentiviral airway gene transfer in lungs of mice and sheep: successes and challenges. J Gene Med 2010; 12: 647-658.
52. Ferrari S, Griesenbach U, Iida A, et al. Sendai virus-mediated CFTR gene transfer to the airway epithelium. Gene Ther 2007; 14: 1371-1379.
53. Medina MF, Kobinger GP, Rux J, et al. Lentiviral vectors pseudotyped with minimal filovirus envelopes increased gene transfer in murine lung. Mol Ther 2003; 8: 777-789.
54. Grimm D, Pandey K, Kay MA. Adeno-associated virus vectors for short hairpin RNA expression. Meth Enzymol 2005; 392: 381-405.
55. Limberis MP, Vandenberghe LH, Zhang L, Pickles RJ, Wilson JM. Transduction efficiencies of novel AAV vectors in mouse airway epithelium in vivo and human ciliated airway epithelium in vitro. Mol Ther 2009; 17: 294-301.
56. Stoltz DA, Meyerholz DK, Pezzulo AA, et al. Cystic fibrosis pigs develop lung disease and exhibit defective bacterial eradication at birth. Sci Transl Med 2010; 2: 29ra31.
57. Sun X, Sui H, Fisher JT, et al. Disease phenotype of a ferret CFTR-knockout model of cystic fibrosis. J Clin Invest 2010; 120: 3149-3160.